3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
19
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
9
Stomach Neoplasms
4
Vulvar Neoplasms
3
Vaginal Neoplasms
2
Peritoneal Neoplasms
2
Mesothelioma, Malignant
2
Carcinoma, Ovarian Epithelial
2
Brenner Tumor
2
Vomiting
1
Uterine Neoplasms
1
Triple Negative Breast Neoplasms
1
Sertoli-Leydig Cell Tumor
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrent Uterine Corpus Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Penile Neoplasms
1
Pelvic Neoplasms
1
Ovarian gynandroblastoma
1
Neoplasm Metastasis
1
Nausea
1
Lung Neoplasms
1
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified
1
Locally Advanced Cervical Carcinoma
1
Locally Advanced Cervical Adenocarcinoma
1
Liposarcoma
1
HIV Infections
1
Interventions
Doxorubicin
6
Ifosfamide
4
Filgrastim
3
belinostat
2
Radiotherapy
2
Imatinib Mesylate
2
sodium thiosulfate
1
saracatinib
1
perifosine
1
brostallicin
1
X-Rays
1
Vincristine
1
Trabectedin
1
Therapeutics
1
Temozolomide
1
Sunitinib
1
Specimen Handling
1
Radiation, Ionizing
1
Quality of Life
1
Platinum
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Mass Spectrometry
1
Magnetic Resonance Spectroscopy
1
Injections
1
Immunotherapy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fulvestrant
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
Platinum
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled